EP1556024A4 - Pulsatile release compositions of milnacipran - Google Patents

Pulsatile release compositions of milnacipran

Info

Publication number: EP1556024A4
Authority: EP; European Patent Office
Prior art keywords: milnacipran; release compositions; pulsatile release; pulsatile; compositions
Prior art date: 2002-10-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03809957A

Other languages

German (de)

French (fr)

Other versions

EP1556024A1 (en

Inventor

Jane Hirsh

Roman V Rariy

Michael Heffernan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Collegium Pharmaceutical Inc

Original Assignee

Collegium Pharmaceutical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-10-25

Filing date

2003-10-22

Publication date

2007-01-17

2003-10-22 Application filed by Collegium Pharmaceutical Inc filed Critical Collegium Pharmaceutical Inc

2005-07-27 Publication of EP1556024A1 publication Critical patent/EP1556024A1/en

2007-01-17 Publication of EP1556024A4 publication Critical patent/EP1556024A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP03809957A 2002-10-25 2003-10-22 Pulsatile release compositions of milnacipran Withdrawn EP1556024A4 (en)

Applications Claiming Priority (19)

Application Number	Priority Date	Filing Date	Title
US42164002P	2002-10-25	2002-10-25
US421640P		2002-10-25
US43162702P	2002-12-05	2002-12-05
US43162602P	2002-12-05	2002-12-05
US431626P		2002-12-05
US431627P		2002-12-05
US43186102P	2002-12-09	2002-12-09
US43190602P	2002-12-09	2002-12-09
US431861P		2002-12-09
US431906P		2002-12-09
US44361803P	2003-01-29	2003-01-29
US443618P		2003-01-29
US45899503P	2003-03-28	2003-03-28
US45906103P	2003-03-28	2003-03-28
US45899403P	2003-03-28	2003-03-28
US459061P		2003-03-28
US458994P		2003-03-28
US458995P		2003-03-28
PCT/US2003/033685 WO2004039361A1 (en)	2002-10-25	2003-10-22	Pulsatile release compositions of milnacipran

Publications (2)

Publication Number	Publication Date
EP1556024A1 EP1556024A1 (en)	2005-07-27
EP1556024A4 true EP1556024A4 (en)	2007-01-17

Family

ID=36650219

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03809957A Withdrawn EP1556024A4 (en)	2002-10-25	2003-10-22	Pulsatile release compositions of milnacipran

Country Status (6)

Country	Link
EP (1)	EP1556024A4 (en)
JP (1)	JP2006506461A (en)
AU (1)	AU2003301762B2 (en)
CA (1)	CA2503121A1 (en)
MX (1)	MXPA05004422A (en)
WO (1)	WO2004039361A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003284005B2 (en) *	2002-10-03	2009-12-17	Forest Laboratories Holdings Limited	Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
US20040121010A1 (en) *	2002-10-25	2004-06-24	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
AR042806A1 (en)	2002-12-27	2005-07-06	Otsuka Pharma Co Ltd	COMBINATION OF CARBOSTIRILE DERIVATIVES AND INHIBITORS OF SEROTONINE REABSORTION FOR THE TREATMENT OF ANIMO DISORDERS
NZ540054A (en)	2002-12-27	2007-09-28	Otsuka Pharma Co Ltd	Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
TWI338583B (en) *	2004-05-20	2011-03-11	Otsuka Pharma Co Ltd	Solid pharmaceutical formulation
EP1894565B1 (en) *	2005-06-10	2013-10-30	Pierre Fabre Médicament S.A.	Stabilized milnacipran formulation
WO2007064845A1 (en) *	2005-11-29	2007-06-07	Pr Pharmaceuticals, Inc.	Sustained release butorphanol drug delivery compositions for analgesia
EP1993518A4 (en) *	2006-03-06	2012-12-12	Pozen Inc	Dosage forms for administering combinations of drugs
US9265732B2 (en)	2006-03-06	2016-02-23	Pozen Inc.	Dosage forms for administering combinations of drugs
AR071706A1 (en) *	2008-05-15	2010-07-07	Otsuka Pharma Co Ltd	A PHARMACEUTICAL FORMULATION OF CILOSTAZOL SOLIDA OF SUSTAINED LIBERATION AND METHOD OF PREPARATION.
WO2011107921A2 (en)	2010-03-04	2011-09-09	Ranbaxy Laboratories Limited	Modified release composition of milnacipran
WO2011107922A2 (en)	2010-03-04	2011-09-09	Ranbaxy Laboratories Limited	Extended release composition of milnacipran
RU2013121270A (en)	2010-10-12	2014-11-20	Серекор Инк.	COMPOUNDS AGAINST COUGH CONTAINING MEMANTINE
US11464756B1 (en)	2017-05-19	2022-10-11	Jerry Darm	Mecuna pruriens, L-DOPA and 5-HTP based dietary supplements, pharmaceutical formulations and uses thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0759299A1 (en) *	1995-08-16	1997-02-26	Eli Lilly And Company	Potentiation of serotonin response
WO1998008495A1 (en) *	1996-08-28	1998-03-05	Pierre Fabre Medicament	Galenic formula with extended release of milnacipran
WO1999059593A1 (en) *	1998-05-21	1999-11-25	Eli Lilly And Company	Combination therapy for treatment of depression
WO2000040224A1 (en) *	1999-01-07	2000-07-13	Elan Corporation, Plc	Multiparticulate oral dosage forms
JP2003277252A (en) *	2002-03-20	2003-10-02	Asahi Kasei Corp	Method for producing granular coated preparation
WO2004037190A2 (en) *	2002-10-25	2004-05-06	Collegium Pharmaceutical, Inc.	Modified release compositions of milnacipran
WO2004067039A1 (en) *	2003-01-28	2004-08-12	Collegium Pharmaceutical, Inc.	Multiparticulate compositions of milnacipran for oral administration

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5609884A (en) *	1992-08-31	1997-03-11	G. D. Searle & Co.	Controlled release naproxen sodium plus naproxen combination tablet
US6103263A (en) *	1994-11-17	2000-08-15	Andrx Pharmaceuticals, Inc.	Delayed pulse release hydrogel matrix tablet
SE9704870D0 (en) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulation I
EP1165054A4 (en) *	1999-04-06	2005-02-09	Pharmaquest Ltd	Pharmaceutical dosage form for pulsatile delivery of methylphenidate
EP1064937A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
CA2380333A1 (en) *	1999-08-26	2001-03-01	Christian Andina	Pharmaceutical formulations
US20020028240A1 (en) *	2000-04-17	2002-03-07	Toyohiro Sawada	Timed-release compression-coated solid composition for oral administration
AU2001261434A1 (en) *	2000-05-11	2001-11-26	Pharmacia Corporation	Aldosterone antagonist composition for release during aldosterone acrophase

2003
- 2003-10-22 WO PCT/US2003/033685 patent/WO2004039361A1/en active Application Filing
- 2003-10-22 AU AU2003301762A patent/AU2003301762B2/en not_active Ceased
- 2003-10-22 JP JP2005501896A patent/JP2006506461A/en active Pending
- 2003-10-22 CA CA002503121A patent/CA2503121A1/en not_active Abandoned
- 2003-10-22 EP EP03809957A patent/EP1556024A4/en not_active Withdrawn
- 2003-10-22 MX MXPA05004422A patent/MXPA05004422A/en active IP Right Grant

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0759299A1 (en) *	1995-08-16	1997-02-26	Eli Lilly And Company	Potentiation of serotonin response
WO1998008495A1 (en) *	1996-08-28	1998-03-05	Pierre Fabre Medicament	Galenic formula with extended release of milnacipran
WO1999059593A1 (en) *	1998-05-21	1999-11-25	Eli Lilly And Company	Combination therapy for treatment of depression
WO2000040224A1 (en) *	1999-01-07	2000-07-13	Elan Corporation, Plc	Multiparticulate oral dosage forms
JP2003277252A (en) *	2002-03-20	2003-10-02	Asahi Kasei Corp	Method for producing granular coated preparation
WO2004037190A2 (en) *	2002-10-25	2004-05-06	Collegium Pharmaceutical, Inc.	Modified release compositions of milnacipran
WO2004067039A1 (en) *	2003-01-28	2004-08-12	Collegium Pharmaceutical, Inc.	Multiparticulate compositions of milnacipran for oral administration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2004039361A1 *

Also Published As

Publication number	Publication date
EP1556024A1 (en)	2005-07-27
WO2004039361A1 (en)	2004-05-13
CA2503121A1 (en)	2004-05-13
MXPA05004422A (en)	2007-11-22
AU2003301762B2 (en)	2006-02-09
AU2003301762A1 (en)	2004-05-25
JP2006506461A (en)	2006-02-23

Publication	Publication Date	Title
EP1578403A4 (en)	2007-01-03	Modified release compositions of milnacipran
TWI347198B (en)	2011-08-21	Fenofibrate compositions
PL1610784T3 (en)	2017-02-28	Forms of 5-azacytidine
ZA200508997B (en)	2007-02-28	Preparation of an osteoinductive agent
IL176584A0 (en)	2006-10-31	Photoresist compositions and processes of use
ZA200605348B (en)	2007-04-25	Solid forms of anti-EGFR-antibodies
GB0212062D0 (en)	2002-07-03	Jetable compositions
IL152127A0 (en)	2003-05-29	Probiotic compositions for the treatment of inflammatory bowel disease
EP1603543A4 (en)	2009-03-04	Therapeutic compositions
GB0224415D0 (en)	2002-11-27	Compositions
PL1615622T3 (en)	2012-12-31	Once daily formulations of doxycyclines
IL173738A0 (en)	2006-07-05	Modafinil modified release pharmaceutical compositions
EP1556023A4 (en)	2010-06-02	Nutritional or therapeutic compositions
EP1556024A4 (en)	2007-01-17	Pulsatile release compositions of milnacipran
GB0208609D0 (en)	2002-05-22	Compositions
EP1638394A4 (en)	2009-11-11	Highly concentrated bromine compositions and methods of preparation
GB0222945D0 (en)	2002-11-13	Therapeutic compositions
GB0229258D0 (en)	2003-01-22	Medicinal compositions
AU2003302372A8 (en)	2004-06-18	Formulations of finasteride
GB0221894D0 (en)	2002-10-30	Compositions
PL372655A1 (en)	2005-07-25	Compositions of pentafluoropropane
AU2003282722A8 (en)	2004-04-23	Therapeutic compositions
AU2003269904A8 (en)	2004-01-23	Antigen-polymer compositions
GB0203395D0 (en)	2002-03-27	Compositions
AU2003294684A8 (en)	2004-07-09	Ketoprofen compositions and methods of making them

Legal Events

Date	Code	Title	Description
2005-06-10	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-07-27	17P	Request for examination filed	Effective date: 20050430
2005-07-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-07-27	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2006-02-15	DAX	Request for extension of the european patent (deleted)
2007-01-17	A4	Supplementary search report drawn up and despatched	Effective date: 20061215
2007-01-17	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 9/48 20060101ALI20061211BHEP Ipc: A61K 47/48 20060101AFI20061211BHEP
2007-09-26	17Q	First examination report despatched	Effective date: 20070823
2009-08-19	RIN1	Information on inventor provided before grant (corrected)	Inventor name: SRINIVAS, G RAO, DR. Inventor name: HEFFERNAN, MICHAEL Inventor name: RARIY, ROMAN, V. Inventor name: HIRSH, JANE
2011-10-28	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2011-11-30	18D	Application deemed to be withdrawn	Effective date: 20110503